Article thumbnail

Impact of obesity on ribavirin concentrations.

By Åsa Alsiö (321573), Karolina Rembeck (321574), Galia Askarieh (321575), Peer Brehm Christensen (213500), Martti Färkkilä (321576), Nina Langeland (57003), Mads Rauning Buhl (321577), Court Pedersen (38784), Kristine Mørch (321579), Bart L. Haagmans (253561), Salmir Nasic (321581), Johan Westin (321583), Kristoffer Hellstrand (321584), Gunnar Norkrans (321586) and Martin Lagging (321589)


<p>Box plots displaying the 10<sup>th</sup>, 25<sup>th</sup>, 50<sup>th</sup>, 75<sup>th</sup>, and 90<sup>th</sup> percentiles of the plasma concentrations of ribavirin (µg/mL) treatment day 29 and week 12 (<b>A</b> and <b>B</b> respectively). P-values obtained using Mann-Whitney U-test.</p

Topics: Pharmacology, Infectious Diseases, Virology, obesity, ribavirin
Year: 2013
DOI identifier: 10.1371/journal.pone.0037521.g003
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.